Putman Media Announces Editorial Advisory Board for Website Dedicated to Pharmaceutical Quality by Design

Share Article

Representatives of industry, FDA and academia will guide PharmaQbD.com, a site that will chronicle the QbD movement sweeping the drug industry and help advance a more scientific approach to drug development.

On October 14, Putman Media will officially launch PharmaQbD.com, the first web site dedicated to advancing Quality by Design within the pharmaceutical industry. A demonstration site is already available at http://www.PharmaQbD.com, where visitors can view sample content, sign up for the bi-monthly PharmaQbD E-news, and register for an important webcast, Quality by Design: The Road Ahead, to air live on October 14 to celebrate the launch of PharmaQbD.com.

PharmaQbD.com is a community-oriented web site that will help advance a smarter, more scientific approach to drug development. "We believe that scientific inquiry and experiment are not at odds with business strength," says Agnes Shanley, editor in chief, who notes that the mission statement for the new site and newsletter is "Better Science. Better Business." Shanley is also the editor of PharmaQbD's sister publication, Pharmaceutical Manufacturing magazine (http://www.PharmaManufacturing.com).

The editorial advisory board for the new site has also been announced, comprised of some of the leading experts on QbD within the drug industry:

John Avellanet, CEO, Cerulean Associates
Ranjit Barshikar, GMP/Quality Consultant
Prabir Basu, Executive Director, National Institute for Pharmaceutical Technology and Education
Bikash Chatterjee, President, Pharmatech Associates
Joseph De Feo, CEO, Juran Institute
Alistair Gillanders, CTO and VP North America, DynoChem, Inc.
Steve Jolley , Vice President of Pharmacovigilance, Patni Life Sciences
Jason Kamm, Principal, Tunnell Consulting
Michael Kowolenko, Senior VP, Wyeth Biotech
Michael Meagher, Professor, University of Nebraska-Lincoln
Justin Neway, CSO, Aegis Analytical
Moheb Nasr, Director, Office of New Drug Quality Assessment, FDA
Rakesh Patel, Assistant Professor, Ganpat University, India
Russ Somma, President, SommaTech, Inc.

The concept of Quality by Design is one familiar to many industries, but just taking root within pharmaceuticals. QbD is a systematic approach to drug quality, espoused by the Food & Drug Administration, that asks manufacturers to build in drug quality from early development through the entire product lifecycle, whereas the traditional focus of quality has been on the final product.

In order to stay on top of current trends within the QbD community, PharmaQbD E-news will feature regular interviews and communication with experts and professionals directly involved in QbD, those best qualified to comment on the successes and challenges of this new vision for the pharma industry.

"We hope that PharmaQbD.com and PharmaQbD E-news will be catalysts for the continued growth of the Quality by Design movement within the pharmaceutical industry," says Tonia Becker, publisher of Putman Media's life sciences group, which includes Pharmaceutical Manufacturing magazine and PharmaManufacturing.com. "QbD is not a fad, but a philosophy that is guiding change within every aspect of the drug industry."

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website